Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapitalG is Alphabet's independent growth fund focused on investing in and supporting growth-stage technology companies. It leverages the expertise and resources of Alphabet and Google to help portfolio companies scale through operational support, strategic guidance, and access to networks. The firm manages approximately $7 billion in assets and has supported over 100 investments with notable exits including IPOs and M&A[1][2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapitalG.